Episode #69: Understanding the Financial Burden of IBD | Kevin Harlen & Laura Wingate | Crohn’s & Colitis Foundation

Kevin Harlen interviews Laura Wingate, chief education, support, and advocacy officer with the Crohn’s & Colitis Foundation about a recent survey which shows that more than 40 percent of patients with inflammatory bowel disease (IBD) have made significant financial trade-offs to afford their healthcare.

Continue reading “Episode #69: Understanding the Financial Burden of IBD | Kevin Harlen & Laura Wingate | Crohn’s & Colitis Foundation”

Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)

This summer, four new biosimilar drugs became available to U.S. patients and several more are expected to hit the market soon.

Dr. Michael Weinstein interviews Laura D. Wingate, executive vice president, education, support, & advocacy for the Crohn’s & Colitis Foundation about the positive and negative implications of this development for patients.

Continue reading “Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)”